FACTORS RESPONSIBLE FOR THE DIFFERENTIAL PROCOAGULANT EFFECTS OF DIVERSE PLASMINOGEN ACTIVATORS IN PLASMA

被引:34
作者
EISENBERG, PR [1 ]
MILETICH, JP [1 ]
SOBEL, BE [1 ]
机构
[1] WASHINGTON UNIV,SCH MED,DIV LAB MED,ST LOUIS,MO 63110
关键词
FIBRINOLYSIS; PLASMINOGEN ACTIVATORS; TISSUE-TYPE PLASMINOGEN ACTIVATOR; THROMBIN; STREPTOKINASE;
D O I
10.1016/0268-9499(91)90003-M
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was designed to define the procoagulant effects of different plasminogen activators in recalcified plasma. Accordingly, a two-stage assay procedure was developed in which citrated plasma was recalcified and incubated for 1-7 min with streptokinase (SK), urokinase (UK), or tissue-plasminogen activator (t-PA). An aliquot of this first-stage plasma was added to second-stage plasma; procoagulant activity was measured as the acceleration of the clotting time compared with that in control first-stage plasma to which plasminogen activators had not been added. With this procedure, second-stage clotting times were significantly accelerated after activation of plasminogen compared with those in control plasma and were shortest with 1000 i.u./ml SK. The presence of increased thrombin activity in the recalcified citrated plasma was verified by measurement of increased concentrations of fibrinopeptide A, which were inhibited by addition of 1 U/ml hirudin or 0.5 U/ml heparin to plasma during incubation with the plasminogen activators. Activation of factor X was induced in plasma incubated with SK. The rate of activation of factor X was increased when thrombin was elaborated. Induction of procoagulant activity was found to be dependent on depletion of alpha-2-antiplasmin and on the presence of plasmin activity in plasma, and could be inhibited by aprotinin. Thus, procoagulant activity in response to pharmacologic activation of plasminogen is dependent on plasmin-mediated activation of factor X, and subsequent activation of prothrombin.
引用
收藏
页码:217 / 224
页数:8
相关论文
共 24 条
[1]   EFFECT OF HEPARIN ON CORONARY ARTERIAL PATENCY AFTER THROMBOLYSIS WITH TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION [J].
BLEICH, SD ;
NICHOLS, TC ;
SCHUMACHER, RR ;
COOKE, DH ;
TATE, DA ;
TEICHMAN, SL .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (20) :1412-1417
[2]   ENHANCEMENT OF THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY PRETREATMENT WITH HEPARIN [J].
CERCEK, B ;
LEW, AS ;
HOD, H ;
YANO, J ;
REDDY, NKN ;
GANZ, W .
CIRCULATION, 1986, 74 (03) :583-587
[3]   THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE [J].
CHESEBRO, JH ;
KNATTERUD, G ;
ROBERTS, R ;
BORER, J ;
COHEN, LS ;
DALEN, J ;
DODGE, HT ;
FRANCIS, CK ;
HILLIS, D ;
LUDBROOK, P ;
MARKIS, JE ;
MUELLER, H ;
PASSAMANI, ER ;
POWERS, ER ;
RAO, AK ;
ROBERTSON, T ;
ROSS, A ;
RYAN, TJ ;
SOBEL, BE ;
WILLERSON, J ;
WILLIAMS, DO ;
ZARET, BL ;
BRAUNWALD, E .
CIRCULATION, 1987, 76 (01) :142-154
[4]   IMPORTANCE OF CONTINUED ACTIVATION OF THROMBIN REFLECTED BY FIBRINOPEPTIDE-A TO THE EFFICACY OF THROMBOLYSIS [J].
EISENBERG, PR ;
SHERMAN, L ;
RICH, M ;
SCHWARTZ, D ;
SCHECHTMAN, K ;
GELTMAN, EM ;
SOBEL, BE ;
JAFFE, AS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (06) :1255-1262
[5]   PARADOXIC ELEVATION OF FIBRINOPEPTIDE A AFTER STREPTOKINASE - EVIDENCE FOR CONTINUED THROMBOSIS DESPITE INTENSE FIBRINOLYSIS [J].
EISENBERG, PR ;
SHERMAN, LA ;
JAFFE, AS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (03) :527-529
[6]   DIFFERENTIAL-EFFECTS OF ACTIVATION OF PROTHROMBIN BY STREPTOKINASE COMPARED WITH UROKINASE AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) [J].
EISENBERG, PR ;
MILETICH, JP ;
SOBEL, BE ;
JAFFE, AS .
THROMBOSIS RESEARCH, 1988, 50 (05) :707-717
[7]   INDUCTION OF MARKED THROMBIN ACTIVITY BY PHARMACOLOGIC CONCENTRATIONS OF PLASMINOGEN ACTIVATORS IN NONANTICOAGULATED WHOLE-BLOOD [J].
EISENBERG, PR ;
MILETICH, JP .
THROMBOSIS RESEARCH, 1989, 55 (05) :635-643
[8]   MARKED PLATELET ACTIVATION INVIVO AFTER INTRAVENOUS STREPTOKINASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION [J].
FITZGERALD, DJ ;
CATELLA, F ;
ROY, L ;
FITZGERALD, GA .
CIRCULATION, 1988, 77 (01) :142-150
[9]  
FRANCIS CW, 1983, J LAB CLIN MED, V102, P220
[10]   COLD PROMOTED ACTIVATION OF FACTOR VII .5. RELATION TO FIBRINOLYTIC SYSTEM [J].
GJONNAESS, H .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1973, 29 (01) :143-153